APA

Ver Elst K. M. M., van Vliet H. D. M., Kappers-Klunne M. C. & Leebeek F. W. G. (20050131). In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease. : Thrombosis and haemostasis.

Chicago

Ver Elst Kristien M M, van Vliet Huub D M, Kappers-Klunne Mies C and Leebeek Frank W G. 20050131. In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease. : Thrombosis and haemostasis.

Harvard

Ver Elst K. M. M., van Vliet H. D. M., Kappers-Klunne M. C. and Leebeek F. W. G. (20050131). In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease. : Thrombosis and haemostasis.

MLA

Ver Elst Kristien M M, van Vliet Huub D M, Kappers-Klunne Mies C and Leebeek Frank W G. In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease. : Thrombosis and haemostasis. 20050131.